Table 3:
Suggested Treatment Recommendations for Cases Interpreted as Moderate or Severe Dysplasia by Pathologists’ Characteristics.
| Moderate dysplasia | Severe dysplasia | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
||||||||||
| No. case readings | None | ≤ .5 | .5–1 | ≥ 1 | P-value | None | ≤ .5 | .5–1 | ≥ 1 | P-value | |
| 99 | 420 | 79 | 3 | 10 | 134 | 193 | 16 | ||||
|
| |||||||||||
| Affiliation with academic medical center | |||||||||||
| No | 6432 | 59 (14%) | 316 (72%) | 60 (14%) | 1 (0%) | <0.01 | 6 (2%) | 99 (40%) | 130 (53%) | 12 (5%) | 0.51 |
| Yes | 2544 | 40 (24%) | 104 (63%) | 19 (12%) | 2 (1 %) | 4 (4%) | 35 (33%) | 63 (59%) | 4 (4%) | ||
| Fellowship or board certified in dermatopathology | |||||||||||
| No | 5424 | 35 (10%) | 235 (69%) | 70 (20%) | 3 (1 %) | <0.001 | 6 (3%) | 67 (35%) | 107 (55%) | 14 (7%) | 0.03 |
| Yes | 3552 | 64 (25%) | 185 (72%) | 9 (3%) | 0 (0%) | 4 (3%) | 67 (42%) | 86 (54%) | 2 (1 %) | ||
| Years interpreting melanocytic skin lesions | |||||||||||
| < 10 years | 3552 | 39 (16%) | 182 (73%) | 27 (11%) | 2 (1 %) | 0.34 | 2 (1 %) | 44 (28%) | 100 (65%) | 9 (6%) | <0.01 |
| 10 years + | 5424 | 60 (17%) | 238 (68%) | 52 (15%) | 1 (0%) | 8 (4%) | 90 (45%) | 93 (47%) | 7 (4%) | ||
| Percent of caseload is melanocytic skin lesions | |||||||||||
| < 10 percent | 3792 | 27 (11%) | 173 (72%) | 40 (17%) | 0 (0%) | <0.01 | 4 (3%) | 52 (36%) | 83 (57%) | 6 (4%) | 0.87 |
| ≥ 10 percent | 5184 | 72 (20%) | 247 (68%) | 39 (11%) | 3 (1 %) | 6 (3%) | 82 (39%) | 110 (53%) | 10 (5%) | ||